期刊文献+

曲唑酮与氟西汀治疗围绝经期抑郁症对照研究 被引量:2

A control study of trazodone versus fluoxetine in perimenopa-usal depression
下载PDF
导出
摘要 目的:探讨曲唑酮与氟西汀治疗围绝经期抑郁症的临床疗效和安全性。方法将72例围绝经期抑郁症患者随机分为两组,每组36例,研究组口服曲唑酮治疗,对照组口服氟西汀治疗,观察6周。于治疗前后采用汉密顿抑郁量表、汉密顿焦虑量表评定临床疗效,副反应量表评定不良反应。结果研究组治疗1周末汉密顿焦虑量表总分、汉密顿抑郁量表总分及睡眠因子分显著低于对照组( P<0.05);治疗6周末研究组显效率86.1%、有效率94.4%,对照组分别为77.8%、94.4%,两组比较差异无显著性(χ2=0.84、0,P>0.05)。研究组失眠及焦虑不安发生率显著低于对照组(P<0.05)。结论曲唑酮与氟西汀治疗围绝经期抑郁症疗效均显著,但曲唑酮能够较快改善患者的焦虑及睡眠状况,治疗依从性更好。 Objective To explore the efficacy and safety of trazodone versus fluoxetine in perimenopausal depression .Method Seventy-two patients with perimenopausal depression were randomly assigned to two groups of 36 ones each ,research group took orally trazodone and control group did fluoxetine for 6 weeks . Efficacies were assessed with the Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HA-MA ) before and after treatment and adverse reactions with the Treatment Emergent Symptom Scale (TESS) .Results At the end of the 1st week the HAMA total ,HAMD total and sleep score were signifi-cantly lower in research than in control group (P〈0 .05);at the end of the 6th week obvious effective and effective rate were respectively 86 .1% and 94 .4% in research and 77 .8% and 94 .4% in control group , which showed no significant differences (χ2 =0 .84 ,0 ;P〉0 .05) .The incidences of insomnia and dysphori-a were significantly lower in research than in control group (P〈0 .05) .Conclusion Both trazodone and fluoxetine have an evident effect in the treatment of perimenopausal depression ,but the former could im-prove patients’ anxiety and sleep status more rapidly and has better compliance .
出处 《临床心身疾病杂志》 CAS 2014年第3期33-35,58,共4页 Journal of Clinical Psychosomatic Diseases
关键词 围绝经期抑郁症 心身疾病 心身健康 曲唑酮 氟西汀 汉密顿抑郁量表 汉密顿焦虑量表 Perimenopausal depression psychosomatic disease psychosomatic health trazodone fluoxe-tine HAMD HAMA
  • 相关文献

参考文献15

二级参考文献67

共引文献178

同被引文献22

  • 1胡春丽,李玉凤.舍曲林与米氮平治疗广泛性焦虑对照研究[J].临床心身疾病杂志,2013,19(4):298-299. 被引量:11
  • 2杨瑞珍,孙显斌,莫通,陈良珠.心理干预对妇科恶性肿瘤患者正向情绪的提升效应[J].中国临床康复,2004,8(24):4946-4947. 被引量:10
  • 3李天舒.我国癌症谱呈现新特点[N].健康报,2010-05-28(1).
  • 4张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 5Kanavos P. The rising burden of canner in the develo- ping world [J]. Ann Oncol,2006,17(Suppl 8): viii.
  • 6Hinz A, Krauss O, Hauss JP, et al. Anxiety and de pression in cancer patients compared with the general popula tion[J]. EurJ Cancer Care (Engl) ,2010,19(4) :522.
  • 7Massie MJ. Prevalence of depression in patients withcancer [J]. J Natl Cancer Inst Monogr, 2004, (32):57.
  • 8Que JC, Sy Ortin TT, Anderson KO, et al. Depres sive symptoms among cancer patients in a Philippine tertiary hospital., prevalence, factors, and influence on health-related quality of life[J]. J Palliat Med, 2013,16 (10) : 1280.
  • 9Nutl DJ. Tolerability and safety aspects of mirtazapine [J]. Hum Psychoparmacol, 2002,17 ( 1 ) : S37.
  • 10林永洁,李芬,张剑萍,王良红.西安市更年期妇女健康状况调查分析[J].西安交通大学学报(医学版),2008,29(1):110-114. 被引量:19

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部